Related references
Note: Only part of the references are listed.Age-related distribution of uncommon HPV genotypes in cervical intraepithelial neoplasia grade 3
Luca Giannella et al.
GYNECOLOGIC ONCOLOGY (2021)
Multiple HPV 16 infection with two strains: a possible marker of neoplastic progression
Maria Teresa Bruno et al.
BMC CANCER (2020)
Possibly carcinogenic HPV subtypes are a cause of HSIL and negative clinical HPV tests - A European prospective single center study
Olaf Reich et al.
GYNECOLOGIC ONCOLOGY (2020)
HPV Vaccination: The Position Paper of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV)
Andrea Ciavattini et al.
VACCINES (2020)
HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination
Alyssa M. Cornall et al.
VACCINE (2020)
Cervical Cancer Screening Guidelines in the Postvaccination Era: Review of the Literature
Carlo A. Liverani et al.
JOURNAL OF ONCOLOGY (2020)
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Rebecca B. Perkins et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2020)
Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008-2014
Nancy M. McClung et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Decontamination of Intravaginal Probes Infected by Human Papillomavirus (HPV) Using UV-C Decontamination System
Maxime Pichon et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Age-Related Changes in the Fraction of Cervical Intraepithelial Neoplasia Grade 3 Related to HPV Genotypes Included in the Nonavalent Vaccine
Luca Giannella et al.
JOURNAL OF ONCOLOGY (2019)
Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women
Chelse Spinner et al.
PEDIATRICS (2019)
Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction
Courtney Covert et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
What cervical screening is appropriate for women who have been vaccinated against high risk HPV? A simulation study
Rebecca Landy et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions
Maria Paz-Zulueta et al.
BMC CANCER (2018)
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials
M. Arbyn et al.
EXPERT REVIEW OF VACCINES (2018)
Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer An Observational Cohort Study
Philip E. Castle et al.
ANNALS OF INTERNAL MEDICINE (2018)
Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference
Paolo Giorgi Rossi et al.
PREVENTIVE MEDICINE (2017)
Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain
S. Perez et al.
VIROLOGY JOURNAL (2017)
In vitro assessment of the effect of vaccine-targeted human papillomavirus (HPV) depletion on detection of non-vaccine HPV types: Implications for post-vaccine surveillance studies
Alyssa M. Cornall et al.
JOURNAL OF VIROLOGICAL METHODS (2015)
Invited Commentary: Multiple Human Papillomavirus Infections and Type Replacement-Anticipating the Future After Human Papillomavirus Vaccination
Mahboobeh Safaeian et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2014)
The incidence of human papillomavirus infection following treatment for cervical neoplasia: A systematic review
Anne F. Rositch et al.
GYNECOLOGIC ONCOLOGY (2014)
Comparison of HPV sign Genotyping Test with INNO-LiPA HPV Genotyping Extra assay on histologic and cytologic cervical specimens
Daniela Barbieri et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)
Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer
Peng Guan et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Nitric oxide metabolite levels and assessment of cervical length in the prediction of preterm delivery among women undergoing symptomatic preterm labor
Luca Giannella et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2012)
Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
Beatriz Serrano et al.
INFECTIOUS AGENTS AND CANCER (2012)
The Influence of Multiple Human Papillomavirus Types on the Risk of Genotype-Concordant Incident Infections of the Anus and Cervix: The Hawaii HPV Cohort Study
Marc T. Goodman et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Prevalence of Human Papillomavirus Types in High-Grade Cervical Intraepithelial Neoplasia and Cancer in Italy
Francesca M. Carozzi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
The Reproducibility of CIN Diagnoses Among Different Pathologists Data From Histology Reviews From a Multicenter Randomized Study
Paolo Dalla Palma et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
Share Paper
